Glycopyrrolate; Neostigmine Methylsulfate Patent Expiration
Glycopyrrolate; Neostigmine Methylsulfate was first introduced by Azurity Pharmaceuticals Inc
Glycopyrrolate; Neostigmine Methylsulfate Patents
Given below is the list of patents protecting Glycopyrrolate; Neostigmine Methylsulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Prevduo | US10456354 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Oct 25, 2038 | Azurity |
| Prevduo | US11110054 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Oct 25, 2038 | Azurity |
| Prevduo | US11938217 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Oct 25, 2038 | Azurity |
| Prevduo | US12151020 | Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate | Oct 25, 2038 | Azurity |
Glycopyrrolate; Neostigmine Methylsulfate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List